HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Lopes Selected Research

Therapeutics

9/2022A chloroacetamide derivative as a potent candidate for fusariosis treatment.
3/2021Ex vivo potential of a quinoline-derivative nail lacquer as a new alternative for dermatophytic onychomycosis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Lopes Research Topics

Disease

3Cryptococcosis
12/2019 - 01/2017
2Infections
07/2019 - 01/2018
1Fusariosis
09/2022
1Onychomycosis (Tinea Unguium)
03/2021
1Dermatomycoses
02/2020
1Mycoses (Diseases, Fungus)
07/2019

Drug/Important Bio-Agent (IBA)

2chloroacetamideIBA
09/2022 - 07/2019
2Flucytosine (Ancobon)FDA Link
12/2019 - 01/2017
2Amphotericin B (Amphotericin)FDA LinkGeneric
12/2019 - 01/2017
1quinolineIBA
03/2021
11,3- bis(3,4- dichlorophenoxy)propan- 2- aminium chlorideIBA
02/2020
1CalciumIBA
01/2018
1cryptococcal polysaccharideIBA
01/2018

Therapy/Procedure

2Therapeutics
09/2022 - 03/2021
1Intravenous Administration
12/2019